Clinical trial

An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.

NCT07182214

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2024-05-05

PhaseN/A

Study timeline

Study start (actual)2024-05-05Date precision: day

Registry last updated2025-09-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

Collect blood sampleOTHER

Sponsors & collaborators

Pharus Taiwan, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07182214 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.